ロード中...
PARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future Perspectives
More than simply a promising management option, PARP inhibitors can be regarded as a milestone in the development of personalised treatment of recurrent ovarian carcinoma. Their mechanism of action, known as “synthetic lethality”, is dependent on functional differences of the DNA repair mechanisms o...
保存先:
| 出版年: | Geburtshilfe Frauenheilkd |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Georg Thieme Verlag KG
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4771499/ https://ncbi.nlm.nih.gov/pubmed/26941449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0035-1558185 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|